• Issues related to the quality of cancer care; Health reform implementation related to the regulation and coverage of cancer care and treatments; Health disparities in cancer care; Cancer therapy development; Health information technology.
• Issues pertaining to the federal governments regulation and coverage of cancer care and treatments (Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act - H.R. 6836)

Duration: April 1, 2010 to January 31, 2019

General Issues: Health Issues, Medicare/Medicaid, Budget/Appropriations

Spending: about $1,920,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2010: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Office of Management & Budget (OMB), Vice President of the U.S., White House Office, Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health & Human Services - Dept of (HHS),